2006, ISBN 9780309091565, xvi, 406
Book
Medicine and Science in Sports and Exercise, ISSN 0195-9131, 02/2013, Volume 45, Issue 2, pp. 336 - 341
SMITH, J. W., D. D. PASCOE, D. H. PASSE, B. C. RUBY, L. K. STEWART, L. B. BAKER, and J. J. ZACHWIEJA. Curvilinear Dose-Response Relationship of Carbohydrate...
carbohydrate ingestion rate | Cycling | time trial | TIME-TRIAL PERFORMANCE | OXIDATION | SPORT SCIENCES | CYCLING ENDURANCE PERFORMANCE | FLUID REPLACEMENT | PROLONGED EXERCISE | MUSCLE GLYCOGEN | TIME TRIAL | CARBOHYDRATE INGESTION RATE | INTENSE EXERCISE | INTESTINAL-ABSORPTION | INGESTION | GLUCOSE | CYCLING | Dietary Carbohydrates - administration & dosage | Lactates - blood | Humans | Male | Dose-Response Relationship, Drug | Swimming - physiology | Regression Analysis | Running - physiology | Bicycling - physiology | Adult | Beverages | Physical Endurance - drug effects | Athletic Performance - physiology | Usage | High-carbohydrate diet | Physiological aspects | Carbohydrate metabolism | Research | Cyclists | Health aspects
carbohydrate ingestion rate | Cycling | time trial | TIME-TRIAL PERFORMANCE | OXIDATION | SPORT SCIENCES | CYCLING ENDURANCE PERFORMANCE | FLUID REPLACEMENT | PROLONGED EXERCISE | MUSCLE GLYCOGEN | TIME TRIAL | CARBOHYDRATE INGESTION RATE | INTENSE EXERCISE | INTESTINAL-ABSORPTION | INGESTION | GLUCOSE | CYCLING | Dietary Carbohydrates - administration & dosage | Lactates - blood | Humans | Male | Dose-Response Relationship, Drug | Swimming - physiology | Regression Analysis | Running - physiology | Bicycling - physiology | Adult | Beverages | Physical Endurance - drug effects | Athletic Performance - physiology | Usage | High-carbohydrate diet | Physiological aspects | Carbohydrate metabolism | Research | Cyclists | Health aspects
Journal Article
Journal of Nutrition, ISSN 0022-3166, 02/2009, Volume 139, Issue 2, pp. 271 - 284
Phytosterols (plant sterols and stanols) are well known for their LDL-cholesterol (LDL-C)-lowering effect. A meta-analysis of randomized controlled trials in...
C-REACTIVE PROTEIN | SERUM TOTAL CHOLESTEROL | NUTRITION & DIETETICS | PLASMA-CHOLESTEROL | LOW-FAT YOGURT | BLOOD CHOLESTEROL | PLANT STANOL ESTERS | STEROL-ENRICHED SPREAD | SITOSTANOL-ESTER | DENSITY-LIPOPROTEIN-CHOLESTEROL | RANDOMIZED CONTROLLED-TRIAL | Dose-Response Relationship, Drug | Adult | Cholesterol, LDL - blood | Phytosterols - administration & dosage | Humans | Phytosterols - pharmacology | Dose-response relationship (Biochemistry) | Evaluation | Usage | Low density lipoproteins | Phytosterols | Dietary supplements | Management | Health aspects
C-REACTIVE PROTEIN | SERUM TOTAL CHOLESTEROL | NUTRITION & DIETETICS | PLASMA-CHOLESTEROL | LOW-FAT YOGURT | BLOOD CHOLESTEROL | PLANT STANOL ESTERS | STEROL-ENRICHED SPREAD | SITOSTANOL-ESTER | DENSITY-LIPOPROTEIN-CHOLESTEROL | RANDOMIZED CONTROLLED-TRIAL | Dose-Response Relationship, Drug | Adult | Cholesterol, LDL - blood | Phytosterols - administration & dosage | Humans | Phytosterols - pharmacology | Dose-response relationship (Biochemistry) | Evaluation | Usage | Low density lipoproteins | Phytosterols | Dietary supplements | Management | Health aspects
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 06/2015, Volume 175, Issue 6, pp. 959 - 967
IMPORTANCE The 2008 Physical Activity Guidelines for Americans recommended a minimum of 75 vigorous-intensity or 150 moderate-intensity minutes per week (7.5...
ALL-CAUSE MORTALITY | VIGOROUS EXERCISE | BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE | CARDIOVASCULAR-DISEASE | COHORT | RANDOMIZED CONTROLLED-TRIAL | CORONARY-HEART-DISEASE | PRIMARY PREVENTION | WOMENS HEALTH | United States | Humans | Middle Aged | Mortality | Male | Young Adult | Exercise | Recreation | Aged, 80 and over | Adult | Female | Aged | Cohort Studies | Dose-response relationship (Biochemistry) | Analysis | Longevity | Health aspects
ALL-CAUSE MORTALITY | VIGOROUS EXERCISE | BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE | CARDIOVASCULAR-DISEASE | COHORT | RANDOMIZED CONTROLLED-TRIAL | CORONARY-HEART-DISEASE | PRIMARY PREVENTION | WOMENS HEALTH | United States | Humans | Middle Aged | Mortality | Male | Young Adult | Exercise | Recreation | Aged, 80 and over | Adult | Female | Aged | Cohort Studies | Dose-response relationship (Biochemistry) | Analysis | Longevity | Health aspects
Journal Article
2008, 3rd ed., New ed., ISBN 9780721602004, xvii, 564
Book
1979, ISBN 3540904158, xiii, 207
Book
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 11/2011, Volume 118, Issue 12, pp. 1411 - 1421
Please cite this paper as: Patra J, Bakker R, Irving H, Jaddoe V, Malini S, Rehm J. Dose–response relationship between alcohol consumption before and during...
preterm birth | Alcohol | meta‐analysis | small for gestational age | low birthweight | neonatal development | meta-analysis | MATERNAL DRINKING | FETAL-GROWTH | NATIONAL SAMPLE | BINGE-DRINKING | HEALTH-COMPROMISING BEHAVIORS | DELIVERY | OBSTETRICS & GYNECOLOGY | WOMEN | CIGARETTE-SMOKING | PRENATAL ALCOHOL | EXPOSURE | Infant, Low Birth Weight | Humans | Risk Factors | Risk | Premature Birth - epidemiology | Alcohol Drinking - adverse effects | Dose-Response Relationship, Drug | Pregnancy | Regression Analysis | Alcohol Drinking - epidemiology | Female | Infant, Small for Gestational Age | Infant, Newborn | Fetal alcohol syndrome | Pregnant women | Infants (Premature) | Effect of alcohol on | Fetus | Drinking of alcoholic beverages | Beverages | Public health
preterm birth | Alcohol | meta‐analysis | small for gestational age | low birthweight | neonatal development | meta-analysis | MATERNAL DRINKING | FETAL-GROWTH | NATIONAL SAMPLE | BINGE-DRINKING | HEALTH-COMPROMISING BEHAVIORS | DELIVERY | OBSTETRICS & GYNECOLOGY | WOMEN | CIGARETTE-SMOKING | PRENATAL ALCOHOL | EXPOSURE | Infant, Low Birth Weight | Humans | Risk Factors | Risk | Premature Birth - epidemiology | Alcohol Drinking - adverse effects | Dose-Response Relationship, Drug | Pregnancy | Regression Analysis | Alcohol Drinking - epidemiology | Female | Infant, Small for Gestational Age | Infant, Newborn | Fetal alcohol syndrome | Pregnant women | Infants (Premature) | Effect of alcohol on | Fetus | Drinking of alcoholic beverages | Beverages | Public health
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 2009, Volume 17, Issue 19, pp. 6862 - 6871
The biological importance of microtubules in mitosis and cell division makes them an interesting target for the development of anticancer agents. Small...
Antiproliferative agents | Colchicine | Combretastatin-A4 | Benzo[ b]furan derivatives | Antitubulin agents | Benzo[b]furan derivatives | CHEMISTRY, MEDICINAL | COMBRETASTATIN-A-4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIMITOTIC AGENTS | ANTINEOPLASTIC AGENTS | CHEMISTRY, ORGANIC | CANCER | DISCOVERY | PHOSPHATE | GROWTH | BIOLOGICAL EVALUATION | Tubulin Modulators - pharmacology | Antineoplastic Agents - chemical synthesis | Humans | Protein Multimerization | Benzofurans - chemical synthesis | Benzofurans - pharmacology | Structure-Activity Relationship | Dose-Response Relationship, Drug | Tubulin Modulators - chemical synthesis | Drug Design | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Cell Cycle - drug effects | Binding Sites | Polymerization | Thiophene | Tubulins | Heterocyclic aromatic compounds
Antiproliferative agents | Colchicine | Combretastatin-A4 | Benzo[ b]furan derivatives | Antitubulin agents | Benzo[b]furan derivatives | CHEMISTRY, MEDICINAL | COMBRETASTATIN-A-4 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIMITOTIC AGENTS | ANTINEOPLASTIC AGENTS | CHEMISTRY, ORGANIC | CANCER | DISCOVERY | PHOSPHATE | GROWTH | BIOLOGICAL EVALUATION | Tubulin Modulators - pharmacology | Antineoplastic Agents - chemical synthesis | Humans | Protein Multimerization | Benzofurans - chemical synthesis | Benzofurans - pharmacology | Structure-Activity Relationship | Dose-Response Relationship, Drug | Tubulin Modulators - chemical synthesis | Drug Design | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Cell Cycle - drug effects | Binding Sites | Polymerization | Thiophene | Tubulins | Heterocyclic aromatic compounds
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 05/2016, Volume 59, Issue 10, pp. 5011 - 5021
We recently reported on the discovery of a novel antibacterial (2) with a 4(3H)-quinazolinone core. This discovery was made by in silico screening of 1.2...
BETA-LACTAM RESISTANCE | IN-VITRO | CHEMISTRY, MEDICINAL | BACTERIAL-INFECTIONS | BAD BUGS | BROAD-SPECTRUM CEPHALOSPORIN | NO ESKAPE | INFECTIOUS-DISEASES-SOCIETY | RESISTANT STAPHYLOCOCCUS-AUREUS | BINDING PROTEIN 2A | ANTIMICROBIAL RESISTANCE | Gram-Positive Bacteria - drug effects | Humans | Quinazolinones - administration & dosage | Structure-Activity Relationship | Mice, Inbred ICR | Hep G2 Cells | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Peritonitis - microbiology | Animals | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - pharmacology | Cell Proliferation - drug effects | Mice | Molecular Structure | Quinazolinones - chemistry | Peritonitis - drug therapy | Quinazolinones - therapeutic use | Anti-Bacterial Agents - administration & dosage | Quinazolinones - pharmacology | Disease Models, Animal | Index Medicus
BETA-LACTAM RESISTANCE | IN-VITRO | CHEMISTRY, MEDICINAL | BACTERIAL-INFECTIONS | BAD BUGS | BROAD-SPECTRUM CEPHALOSPORIN | NO ESKAPE | INFECTIOUS-DISEASES-SOCIETY | RESISTANT STAPHYLOCOCCUS-AUREUS | BINDING PROTEIN 2A | ANTIMICROBIAL RESISTANCE | Gram-Positive Bacteria - drug effects | Humans | Quinazolinones - administration & dosage | Structure-Activity Relationship | Mice, Inbred ICR | Hep G2 Cells | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Peritonitis - microbiology | Animals | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - pharmacology | Cell Proliferation - drug effects | Mice | Molecular Structure | Quinazolinones - chemistry | Peritonitis - drug therapy | Quinazolinones - therapeutic use | Anti-Bacterial Agents - administration & dosage | Quinazolinones - pharmacology | Disease Models, Animal | Index Medicus
Journal Article
2009, Statistics in practice, ISBN 0470447508, xiii, 230
A valuable guide to understanding the problem of quantifying uncertainty in dose response relations for toxic substances In today's scientific research, there...
Environmental toxicology | Toxicology | Mathematical models | Dose-response relationship | Uncertainty
Environmental toxicology | Toxicology | Mathematical models | Dose-response relationship | Uncertainty
Book
Journal of Medicinal Chemistry, ISSN 0022-2623, 12/2016, Volume 59, Issue 24, pp. 11098 - 11109
α-Carbonic anhydrase of Helicobacter pylori (HpαCA) plays an important role in the acclimation of this oncobacterium to the acidic pH of the stomach....
CHEMISTRY, MEDICINAL | INFECTION | CLONING | BINDING | EPIDEMIOLOGY | Sulfonamides - chemistry | Carbonic Anhydrase Inhibitors - chemistry | Models, Molecular | Crystallography, X-Ray | Helicobacter pylori - drug effects | Carbonic Anhydrase Inhibitors - chemical synthesis | Structure-Activity Relationship | Carbonic Anhydrase Inhibitors - pharmacology | Sulfonamides - pharmacology | Carbonic Anhydrases - metabolism | Anti-Bacterial Agents - chemical synthesis | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Sulfonamides - chemical synthesis | Helicobacter pylori - metabolism | Helicobacter pylori - enzymology | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - pharmacology | Molecular Structure
CHEMISTRY, MEDICINAL | INFECTION | CLONING | BINDING | EPIDEMIOLOGY | Sulfonamides - chemistry | Carbonic Anhydrase Inhibitors - chemistry | Models, Molecular | Crystallography, X-Ray | Helicobacter pylori - drug effects | Carbonic Anhydrase Inhibitors - chemical synthesis | Structure-Activity Relationship | Carbonic Anhydrase Inhibitors - pharmacology | Sulfonamides - pharmacology | Carbonic Anhydrases - metabolism | Anti-Bacterial Agents - chemical synthesis | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Sulfonamides - chemical synthesis | Helicobacter pylori - metabolism | Helicobacter pylori - enzymology | Anti-Bacterial Agents - chemistry | Anti-Bacterial Agents - pharmacology | Molecular Structure
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 05/2016, Volume 59, Issue 10, pp. 5121 - 5127
Design, synthesis, and evaluation of α-methylene-γ-butyrolactone analogues and their evaluation as anticancer agents is described. SAR identified a spirocyclic...
CHEMISTRY, MEDICINAL | QUINOXALINE UREA ANALOG | MELAMPOMAGNOLIDE-B | NATURAL-PRODUCTS | BIOLOGICAL EVALUATION | COVALENT DRUGS | TUMOR-CELLS | OVARIAN-CANCER | SESQUITERPENE LACTONE PARTHENOLIDE | NF-KAPPA-B | AMINO-DERIVATIVES | Tumor Necrosis Factor-alpha - metabolism | NF-kappa B - antagonists & inhibitors | Antineoplastic Agents - chemical synthesis | Humans | Isatin - pharmacology | NF-kappa B - metabolism | Structure-Activity Relationship | Isatin - chemistry | Antineoplastic Agents - chemistry | Dose-Response Relationship, Drug | Spiro Compounds - chemical synthesis | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Molecular Structure | Spiro Compounds - chemistry | Spiro Compounds - pharmacology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Drug Screening Assays, Antitumor
CHEMISTRY, MEDICINAL | QUINOXALINE UREA ANALOG | MELAMPOMAGNOLIDE-B | NATURAL-PRODUCTS | BIOLOGICAL EVALUATION | COVALENT DRUGS | TUMOR-CELLS | OVARIAN-CANCER | SESQUITERPENE LACTONE PARTHENOLIDE | NF-KAPPA-B | AMINO-DERIVATIVES | Tumor Necrosis Factor-alpha - metabolism | NF-kappa B - antagonists & inhibitors | Antineoplastic Agents - chemical synthesis | Humans | Isatin - pharmacology | NF-kappa B - metabolism | Structure-Activity Relationship | Isatin - chemistry | Antineoplastic Agents - chemistry | Dose-Response Relationship, Drug | Spiro Compounds - chemical synthesis | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Molecular Structure | Spiro Compounds - chemistry | Spiro Compounds - pharmacology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Drug Screening Assays, Antitumor
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 01/2015, Volume 89, pp. 21 - 31
Drug resistance to chemotherapeutic agents paved the way to develop novel synthetic molecules which are active on MDR cancer cell lines. Regio-isomeric...
Suzuki coupling | Chemotherapy | Cytotoxic studies | Imidazo[4,5-b]pyridine analogues | CHEMISTRY, MEDICINAL | PRIVILEGED STRUCTURES | MECHANISM | ISOXAZOLINE | ANTICANCER AGENTS | NUCLEOSIDES | BOND-FORMING REACTIONS | BIOISOSTERISM | EXPLORATION | INHIBITORS | DERIVATIVES | Purines - chemical synthesis | Cell Survival - drug effects | Purines - pharmacology | Pyridines - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Imidazoles - chemistry | Pyridines - chemical synthesis | Imidazoles - pharmacology | Structure-Activity Relationship | Antineoplastic Agents - chemistry | Dose-Response Relationship, Drug | Purines - chemistry | Drug Design | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Molecular Structure | Pyridines - pharmacology | Imidazoles - chemical synthesis | Drug Screening Assays, Antitumor | Alkaloids | Pyridine | Drug resistance | Cancer
Suzuki coupling | Chemotherapy | Cytotoxic studies | Imidazo[4,5-b]pyridine analogues | CHEMISTRY, MEDICINAL | PRIVILEGED STRUCTURES | MECHANISM | ISOXAZOLINE | ANTICANCER AGENTS | NUCLEOSIDES | BOND-FORMING REACTIONS | BIOISOSTERISM | EXPLORATION | INHIBITORS | DERIVATIVES | Purines - chemical synthesis | Cell Survival - drug effects | Purines - pharmacology | Pyridines - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Imidazoles - chemistry | Pyridines - chemical synthesis | Imidazoles - pharmacology | Structure-Activity Relationship | Antineoplastic Agents - chemistry | Dose-Response Relationship, Drug | Purines - chemistry | Drug Design | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Molecular Structure | Pyridines - pharmacology | Imidazoles - chemical synthesis | Drug Screening Assays, Antitumor | Alkaloids | Pyridine | Drug resistance | Cancer
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2015, Volume 58, Issue 4, pp. 1879 - 1899
Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that acts as a ligand for five G-protein coupled receptors (S1P1–5) whose downstream effects...
CHEMISTRY, MEDICINAL | PHOSPHORYLATION | HUMAN LEUKEMIA | SPHINGOSINE-1-PHOSPHATE | BIOLOGICAL EVALUATION | SPHK INHIBITORS | MICE | CANCER | TYPE-2 | IMMUNOMODULATORY DRUG FTY720 | 1-PHOSPHATE | Dose-Response Relationship, Drug | Phosphotransferases (Alcohol Group Acceptor) - antagonists & inhibitors | Protein Kinase Inhibitors - chemical synthesis | Protein Kinase Inhibitors - chemistry | Guanidine - chemical synthesis | Guanidine - chemistry | Guanidine - pharmacology | Molecular Structure | Protein Kinase Inhibitors - pharmacology | Structure-Activity Relationship | Drug Discovery | Phosphotransferases (Alcohol Group Acceptor) - metabolism
CHEMISTRY, MEDICINAL | PHOSPHORYLATION | HUMAN LEUKEMIA | SPHINGOSINE-1-PHOSPHATE | BIOLOGICAL EVALUATION | SPHK INHIBITORS | MICE | CANCER | TYPE-2 | IMMUNOMODULATORY DRUG FTY720 | 1-PHOSPHATE | Dose-Response Relationship, Drug | Phosphotransferases (Alcohol Group Acceptor) - antagonists & inhibitors | Protein Kinase Inhibitors - chemical synthesis | Protein Kinase Inhibitors - chemistry | Guanidine - chemical synthesis | Guanidine - chemistry | Guanidine - pharmacology | Molecular Structure | Protein Kinase Inhibitors - pharmacology | Structure-Activity Relationship | Drug Discovery | Phosphotransferases (Alcohol Group Acceptor) - metabolism
Journal Article
Psychopharmacology, ISSN 0033-3158, 4/2008, Volume 197, Issue 3, pp. 401 - 408
Ketamine induces effects resembling both positive and negative psychotic symptoms of schizophrenia. These are thought to arise through its action as an...
Psychosis | Negative symptoms | Biomedicine | Ketamine | NMDA | Schizophrenia | Pharmacology/Toxicology | Glutamate | Psychiatry | SPECT | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | HUMANS | MODEL | BLOOD-FLOW | NEUROSCIENCES | psychosis | GLUTAMATERGIC DRUGS | PREFRONTAL CORTEX | STRIATAL DOPAMINE | ketamine | negative symptoms | IN-VIVO | C-11 RACLOPRIDE | PHARMACOLOGY & PHARMACY | glutamate | PET | Single-Blind Method | Schizophrenia - chemically induced | Receptors, N-Methyl-D-Aspartate - drug effects | Humans | Receptors, N-Methyl-D-Aspartate - metabolism | Tomography, Emission-Computed, Single-Photon | Male | Iodine Radioisotopes - pharmacokinetics | Schizophrenia - diagnostic imaging | Ketamine - administration & dosage | Dose-Response Relationship, Drug | Brief Psychiatric Rating Scale | Ketamine - toxicity | Psychoses, Substance-Induced - diagnostic imaging | Prefrontal Cortex - drug effects | Psychoses, Substance-Induced - physiopathology | Ketamine - pharmacokinetics | Adult | Guanidines - pharmacokinetics | Infusions, Intravenous | Prefrontal Cortex - diagnostic imaging | Psychotropic drugs | Neurotransmitters | Pharmacology | Brain research | Binding sites | Index Medicus
Psychosis | Negative symptoms | Biomedicine | Ketamine | NMDA | Schizophrenia | Pharmacology/Toxicology | Glutamate | Psychiatry | SPECT | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | HUMANS | MODEL | BLOOD-FLOW | NEUROSCIENCES | psychosis | GLUTAMATERGIC DRUGS | PREFRONTAL CORTEX | STRIATAL DOPAMINE | ketamine | negative symptoms | IN-VIVO | C-11 RACLOPRIDE | PHARMACOLOGY & PHARMACY | glutamate | PET | Single-Blind Method | Schizophrenia - chemically induced | Receptors, N-Methyl-D-Aspartate - drug effects | Humans | Receptors, N-Methyl-D-Aspartate - metabolism | Tomography, Emission-Computed, Single-Photon | Male | Iodine Radioisotopes - pharmacokinetics | Schizophrenia - diagnostic imaging | Ketamine - administration & dosage | Dose-Response Relationship, Drug | Brief Psychiatric Rating Scale | Ketamine - toxicity | Psychoses, Substance-Induced - diagnostic imaging | Prefrontal Cortex - drug effects | Psychoses, Substance-Induced - physiopathology | Ketamine - pharmacokinetics | Adult | Guanidines - pharmacokinetics | Infusions, Intravenous | Prefrontal Cortex - diagnostic imaging | Psychotropic drugs | Neurotransmitters | Pharmacology | Brain research | Binding sites | Index Medicus
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 07/2017, Volume 60, Issue 13, pp. 5556 - 5585
We have identified a series of positive allosteric NMDA receptor (NMDAR) modulators derived from a known class of GluN2C/D-selective tetrahydroisoquinoline...
Allosteric Regulation - drug effects | Tetrahydroisoquinolines - pharmacology | Administration, Oral | Humans | Microsomes, Liver - metabolism | Receptors, N-Methyl-D-Aspartate - metabolism | Models, Molecular | Crystallography, X-Ray | Structure-Activity Relationship | Tetrahydroisoquinolines - administration & dosage | Microsomes, Liver - chemistry | Dose-Response Relationship, Drug | Tetrahydroisoquinolines - chemistry | Molecular Structure
Allosteric Regulation - drug effects | Tetrahydroisoquinolines - pharmacology | Administration, Oral | Humans | Microsomes, Liver - metabolism | Receptors, N-Methyl-D-Aspartate - metabolism | Models, Molecular | Crystallography, X-Ray | Structure-Activity Relationship | Tetrahydroisoquinolines - administration & dosage | Microsomes, Liver - chemistry | Dose-Response Relationship, Drug | Tetrahydroisoquinolines - chemistry | Molecular Structure
Journal Article